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Abstract: Chronic widespread musculoskeletal pain (CWP) is a condition manifesting varied 
co-symptomatology and considerable heterogeneity in symptom profiles. This poses an obstacle 
for disease definition and effective treatment. Latent class analysis (LCA) provides an opportunity 
to find subtypes of cases in multivariate data. In this study, LCA was used to investigate whether 
and how individuals with CWP could be classified according to 12 additional somatic symptoms 
(migraine headaches, insomnia, stiffness, etc.). In a second step, the role of psychological and 
coping factors for the severity of these co-symptoms was investigated. Data were available for 
a total of N = 3,057 individuals (mean age = 56.6 years), with 15.4% suffering from CWP. In 
the latter group, LCA resulted in a three-class solution (n
group1
 = 123; n
group2
 = 306; n
group3
 = 43) 
with groups differing in a graded fashion (i.e., severity) rather than qualitatively for somatic 
co-symptom endorsements. A consistent picture emerged, with individuals in the first group 
reporting the lowest scores and individuals in group 3 reporting the highest. Additionally, more 
co-symptomatology was associated with higher rates of anxiety sensitivity and depression, as 
well as more extraversion and emotional instability. No group differences for any of the coping 
strategies could be identified. The findings suggest that CWP has several detectable subtypes 
with distinct psychological correlates. The identification of CWP subgroups is important for 
understanding disease mechanisms and refining prognosis as well as stratifying patients in clini-
cal trials and targeting specific treatment at the subgroups most likely to respond.
Keywords: anxiety sensitivity, extraversion, depression, emotional stability, somatoform 
symptoms
Introduction
Chronic widespread musculoskeletal pain (CWP) is the core symptom of fibromyalgia 
(FM) affecting up to 18% of the general population and representing an important 
measure of the global burden of pain.1,2 CWP has been given a standard definition by the 
American College of Rheumatology, emphasizing axial pain as a constant feature and 
the presence of pain in the left and right sides of the body, above and below the waist.3 
CWP is more prevalent in females than in males.4,5 The condition has been related to a 
number of psychological and medical conditions and complaints, such as depression, 
anxiety, fatigue, distress, and other somatic symptoms.6,7 The processes underlying 
the development, prognosis, and treatment of CWP are of a complex nature. Findings 
from the numerous studies on CWP indicate that factors other than biomechanical or 
neurophysiologic ones may have much greater impact on the condition and that the 
disease can therefore be best explained by a biopsychosocial model.8–10 Therefore, 
recently, the exploration of psychological entities and cognitive behavioral factors has 
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been given more attention and the importance of personality 
traits and illness coping (i.e., referring to the emotional and 
behavioral response strategies, such as avoidance or magni-
fication) has repeatedly been demonstrated.11–14
The prognosis for many chronic pain conditions such 
as CWP has been found to be influenced by psychological 
factors such as anxiety or depression. Especially, the relation-
ship between depression and chronic pain has been subject 
to extensive research, and studies have consistently found an 
association between depressive symptoms and higher levels 
of pain intensity, more functional limitation and disability, 
and worse prognosis.7,15 Furthermore, a link between anxiety 
sensitivity (AS) – describing the fear of anxiety sensations 
and their believed negative consequences – in the maintenance 
of chronic pain and disability has been reported.16 Similarly, 
the importance of personality as part of the biopsychosocial 
disease approach has been established in numerous studies. 
Personality traits seem to influence an individual’s reaction and 
coping with CWP, with the fundamental personality trait of 
neuroticism (i.e., referring to the relatively stable tendencies to 
respond with negative emotions to threat, frustration, or loss) 
being especially relevant.17 Apart from these psychological 
factors, cognitive–behavioral variables such as individual cop-
ing have also been implicated in CWP. Studies investigating 
the importance of individual coping have identified a set of 
adaptive and maladaptive coping strategies associated with 
adjustment in chronic pain, suggesting them to represent 
premorbid risk or protective factors for the development and/
or maintenance of CWP.14 In this context, coping refers to the 
emotional and behavioral response strategies to problems/
stressors, such as avoidance or magnification. Acknowledg-
ment of these psycho-affective factors in pain chronification 
seems important also in relation to the theory of “central 
sensitization”. Central sensitization describes an increase in 
the excitability and synaptic efficacy of neurons in central 
nociceptive pathways, manifesting itself in hypersensitivity, 
allodynia, and hyperalgesia. Besides specific neurophysiologi-
cal changes to the nervous system, neuroplastic alterations 
in nociceptive sensitivity are also more likely to occur due to 
psychological and environmental predisposing factors (such 
as preexisting anxiety about pain).18,19
CWP, together with FM, is also a condition of varied 
co-symptomatology and shows considerable heterogeneity 
in symptom profiles.20–24 The multidimensional nature of the 
condition fuels the debate over disease definition and poses 
an obstacle for efficient and effective research, partly due to 
the lack of specific disease markers. It further hinders more 
in-depth exploration of the interactions among its clinical 
features and their association with treatment outcomes. While 
CWP and its associated comorbidities have been fairly well 
studied, the empirical symptomatic heterogeneity of CWP 
and how it potentially relates to personality and disease cop-
ing has been neglected so far. Hence, little is known about the 
etiology of co-symptoms, and this hampers the understanding 
of underlying mechanisms that drive the condition. Identi-
fication of CWP subgroups in terms of co-symptomatology 
severity and how this may relate to psycho-behavioral fac-
tors, however, is necessary not only for the successful out-
comes of future biomedical research that may depend upon 
the accuracy of phenotype description but also has equally 
important clinical implications – both on prevention and on 
management of the condition.
The first aim of this study was to compare levels of co-
symptoms in individuals with and without CWP. We then used 
latent class analyses (LCAs) to investigate whether individu-
als with CWP can be classified according to their additional 
somatic symptoms. Finally, the role of psycho-affective fac-
tors and coping behavior for the extent and severity of these 
co-symptoms was compared between the CWP subgroups.
Participants and methods
Study population
The study sample consisted of unselected Caucasian female 
monozygotic (MZ) and dizygotic (DZ) twins from the Twin-
sUK Registry.25 A large number of previous studies, including 
questionnaires and extensive clinical investigations, have 
shown twins to be comparable with age-matched singletons 
for a variety of disorders and lifestyle factors.26 For more 
information on the TwinsUK cohort.27 For this study, data 
collection by self-report questionnaire for the various traits 
was performed between 2008 and 2013. Excluded from the 
study were twins having known causes of pain such as frac-
ture, cancer, and rheumatoid arthritis. Data on CWP status 
were available for a total of N = 3,057 individuals (M
age
 = 
56.6 years, standard deviation [SD] = 13.8), with 472 (15.4%) 
who fulfilled criteria for CWP (see Assessment instruments 
section). Only one twin per family (random selection) was 
included in the analyses. Ethical approval was obtained by the 
St Thomas’ Hospital Research Ethics Committee. All twins 
provided written consent and were unaware of the research 
hypotheses addressed in this study. The research followed 
the tenets of the Declaration of Helsinki.
Assessment instruments
Sociodemographic characteristics of the participants were 
available from the TwinsUK database. Information on 12 
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somatic co-symptoms including fatigue, migraine, heartburn, 
headache, backache, insomnia, stiffness, palpitations, joint 
pain, dizziness, shaking, and hot and cold spells was col-
lected using a study-specific list that had to be responded on 
a Likert-type scale ranging from “Never” (0) to “Often” (4) 
(question asked: “how often have you suffered from any of 
the following complaints in the last 3 months”).
Chronic widespread pain was screened for using the four 
items pertaining to the “pain subscale” from the London 
Fibromyalgia Epidemiology Symptom Screening question-
naire (LFESSQ).28 The four items ask about pain in the left 
and right of the body and above and below the diaphragm 
lasting at least 7 days in the previous 3 months. To be clas-
sified as having CWP, participants had to respond “yes” to 
all four pain items with either both a right- and a left-side 
positive response or a positive response for pain at both sides. 
The utility of this phenotype assessment has repeatedly been 
demonstrated.20,29
Information on the Big Five personality dimensions was 
collected using the “Ten-Item Personality Index” (TIPI), an 
inventory designed to assess the different personality dimen-
sions with optimized validity.30 The instrument measures very 
broad domains with only two items per dimension and uses 
items at both the positive and negative poles. Hence, the use 
of the TIPI is mainly indicated for situations where short 
measures are needed and personality is not the primary topic 
of interest. Response options are on a 7-point Likert scale 
ranging from “Disagree strongly” (1) to “Agree strongly” 
(7). Dimension scores are created by summing up the two 
item values for the different dimensions. Items 2, 4, 6, 8, and 
10 are reversely scored. Cronbach’s a in this study ranged 
from 0.43 to 0.69.
To assess coping responses, the widely applied COPE 
self-report questionnaire was used.31 The COPE is a 60-item 
measure that yields 15 factors (including positive reinter-
pretation and growth, mental disengagement, focus on and 
venting of emotions, use of instrumental social support, 
active coping, denial, religious coping, humor, behavioral 
disengagement, restraint, use of emotional social sup-
port, substance use, acceptance, suppression of competing 
activities, and planning) to assess active vs. avoidant coping 
strategies.25 Ratings are made on a 4-point Likert-type scale, 
ranging from “I usually don’t do this at all” (1) to “I usually 
do this a lot” (4). The questionnaire shows acceptable psy-
chometric properties with Cronbach’s a ranging from 0.37 
to 0.93, test–retest reliabilities ranging from 0.46 to 0.86 
and strong evidence of discriminant and convergent validity, 
with constructs such as hardiness, optimism, control, and 
self-esteem. For this study, Cronbach’s a ranged from 0.43 
to 0.89, in accordance with results from other studies.
AS was assessed using the 16-item Anxiety Sensitivity 
Index (ASI).32 AS is defined as the fear of arousal-related 
sensations (e.g., fear of heart palpitations) arising from 
beliefs that these anxiety-related sensations have harmful 
consequences. Items are responded on a 5-point Likert-type 
scale ranging from “Very little” (0) to “Very much” (4). The 
psychometric properties and predictive validity of the widely 
used instrument have been well established, and a number 
of studies have provided evidence that the ASI has excel-
lent internal consistency (a = 0.81–0.94), a good degree of 
test–retest reliability (r = 0.71–0.75), and a high degree of 
inter-item relatedness. Cronbach’s a in this study was 0.92.
Information on depression was obtained from the Com-
posite International Diagnostic Interview (CIDI) question-
naire according to the Diagnostic and Statistical Manual of 
Mental Disorders, fourth edition (DSM-IV) criteria for major 
depression disorder (MDD).33 The CIDI was developed by 
the World Health Organization (WHO), and a number of 
studies have demonstrated the psychometric properties of 
the instrument, especially also in terms of the validity of its 
diagnostic assessment against a trained clinical interviewer.33
Statistical analyses
The goals of this study were threefold: 1) comparing symp-
toms between individuals with and without CWP; 2) identify-
ing subgroups for individuals with CWP; and 3) examining 
if individuals in these subgroups differ in personality traits, 
AS, depression, and coping behavior. With respect to the 
first goal, because some of the variables and scales showed 
skewness, Mann–Whitney–Wilcoxon tests (nonparametric 
test, equivalent to t-test) were used to examine whether 
somatic co-symptoms were higher for individuals with 
CWP compared to individuals without CWP. In addition 
to p-values, effect sizes are reported as we expected even 
small differences to show statistical significance due to the 
large sample size. In this study, effect sizes of d = 0.2 were 
considered as small.
We used LCA to detect subgroups of individuals with 
CWP scoring differentially on the somatic co-symptomatol-
ogy. LCA is a structural equation modeling method allowing 
to find hidden groups (i.e., latent classes) of individual with 
similar somatic patterns. This approach allowed us to identify 
specific patterns of associations between the symptoms; e.g., 
some individuals with CWP might score high in symptoms 
a–c but low in symptoms d–f, whereas other individuals 
might be characterized differently. Thus, the LCA enables us 
Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1736
Burri et al
to find subgroups with no a priori definition. To identify the 
optimal number of classes, we used a stepwise approach and 
relied on the Vuong–Lo–Mendell–Rubin (VLMR) fit indices. 
We began with a model based on one class, then allowed the 
model to compute further classes one at the time, which is 
done until the VLMR fit indices become significant, conse-
quently indicating that the model contains one class more 
than the optimal number of classes. To achieve the third goal, 
to identify differences in somatic co-symptoms, personality 
traits, AS, depression, and coping behavior across groups, a 
Kruskal–Wallis test was performed (nonparametric equiva-
lent to analysis of variance [ANOVA]). Where significant, 
Wilcoxon tests were used to identify which specific group 
differed significantly from the others.
Data handling and descriptive analyses were carried out 
using STATA software (StataCorp. 2007, Stata Statistical 
Software: Release 10; StataCorp LP, College Station, TX, 
USA). MPlus 7.3 was used to examine the latent profile 
analysis.34 R was used for the computation of Kruskal–Wallis 
and Wilcoxon tests.35
Results
Sample characteristics comparison of 
individuals with and without CWP
Table 1 shows the sample characteristics of the study vari-
ables in the CWP and the non-CWP groups. In terms of 
co-symptoms, the CWP group consistently reported higher 
scores across all symptoms (d = −0.25 to −1.37) apart from 
migraine (p = 0.31) and dizziness (p = 0.48). In the CWP 
group, the most severe complaint was joint pain, whereas it 
was heartburn for the non-CWP group (Table 1). With regard 
to personality, the CWP group showed higher values in emo-
tional instability compared to individuals without CWP. The 
two groups further differed in the coping strategies restraint 
and emotional support, as can be seen in Table 1.
LCA
LCA resulted in a three-class solution (VLMR fit indices 
p-values: Class
1
 = 0.000; Class
2
 = 0.000; Class
3
 = 0.000; 
Class
4
 = 0.554; n
group1
 = 123; n
group2
 = 306; n
group3
 = 43) with 
the resulting groups differing in a graded fashion (severity) 
rather than qualitatively for somatic co-symptom endorse-
ments (Table 2). A consistent picture emerged, in that indi-
viduals in the first group reported the lowest scores across 
all somatic co-symptoms apart from headache, whereas 
individuals in group 3 reported the highest scores across 
eight of the 12 symptoms. Individuals assigned to the second 
and third groups tended to report more heartburn, low back 
pain, insomnia, joint stiffness, joint pain, dizziness, and hot 
and cold spells compared to individuals in group 1. Simi-
larly, individuals in group 3 reported greater severity across 
all symptoms apart from stiffness, back ache, and joint pain 
compared to groups 1 and 2.
CWP group comparison in terms of 
personality and coping strategies
With regard to personality traits, the three CWP classes dif-
fered significantly in extraversion and emotional instability, 
with group 3 (i.e., highest co-symptomatology) being more 
extravert than groups 1 and 2 and similarly also reporting 
more emotional instability than individuals in groups 1 
and 2 (Table 3). The three groups further differed in AS and 
depression, with group 3 scoring highest in both variables 
compared to groups 1 and 2. No differences in any of the 
coping strategies could be found between the three CWP 
groups (Table 3).
Discussion
Individuals with CWP generally report a high rate of comor-
bid symptoms and disorders; therefore, it is not surprising that 
in this study, women with CWP also reported significantly 
more somatic co-symptoms compared to their non-CWP 
counterparts. We extended previous work by identifying 
subgroups that differ in the extent to which they report 
additional symptoms. Here, the most remarkable finding 
is that individuals with CWP can be categorized into three 
statistically distinct classes depending primarily on the num-
ber and severity of their somatic co-symptomatology. CWP 
group 1 reported the least somatic symptoms – apart from 
non-migrainous headache – compared to groups 2 and 3. 
Even in comparison to group 2, the levels of non-migrainous 
headache reported by group 1 were not significantly higher. 
These low levels of somatic co-symptoms suggest that CWP 
group 1is less likely to be “somatizers” and are predominantly 
affected by widespread musculoskeletal pain only, without 
additional symptoms.
Overall, group 3 had the highest scores across eight of 
the 11 symptoms and therefore represents a more “somatiz-
ing” CWP group. Interestingly, while group 3 reported more 
symptoms compared to groups 1 and 2, individuals in group 
2 seemed to differ in a qualitative manner from groups 1 and 
3, by reporting more axial and peripheral joint symptoms 
including joint ache, low back pain, and stiffness than the 
others. This group seems to be particularly distinct from 
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the others by the qualitative nature of their most commonly 
reported co-symptoms. Our findings are comparable to Vin-
cent et al’s reports, where cluster analyses on 581 women with 
FM resulted in four distinguishable groups, differing mainly 
by symptom severity levels (i.e., high to low average levels). 
The two subgroups with moderate symptom severity differed 
mainly in profiles of anxiety and depression.24
Comparing the three groups resulting from the LCA 
in terms of a number of psychological and behavioral cor-
relates showed that the degree of subclinical psychological 
comorbidity (major depression and anxiety) varied across the 
groups. Individuals in group 3 with more somatic symptoms 
were also more likely to report higher levels of depression 
and more AS compared to the other two groups. More than 
40 studies have explored the link between AS and chronic 
pain and have suggested AS to be an important contributing 
variable in the development and maintenance of pain.36,37 
Individuals with elevated AS appear more likely to interpret 
somatic symptoms as aversive or dangerous, fostering cata-
strophic beliefs about pain that increase fear and avoidance 
may lead to poor response to some treatment modalities. A 
similar picture emerges for individuals prone to somatization. 
Table 1 Variable characteristics of individuals without CWP and with CWP
Variable Non-CWP (n = 2,585) CWP (n = 472) p d
M SD M SD
Age 55.30 14.2 62.27 10.87 <0.001 −0.55
Any medical condition 0.11 0.31 0.32 0.47 <0.001 −0.53
AS 13.30 9.21 15.94 9.98 <0.001 −0.27
Depression 0.27 0.45 0.46 0.50 <0.001 −0.39
Symptoms
Fatigue 1.22 1.24 2.11 1.45 <0.001 −0.66
Migraine 0.19 0.39 0.32 0.47 0.314
−
Heartburn 1.36 0.48 1.59 0.49 <0.001 −0.47
Headache 0.86 1.02 1.13 1.16 <0.001 −0.25
Backache 0.77 1.10 2.10 1.52 <0.001 −1.00
Insomnia 0.97 1.23 1.63 1.42 <0.001 −0.50
Stiffness 0.81 1.23 2.53 1.53 <0.001 −1.24
Palpitation 0.31 0.75 0.71 1.11 <0.001 −0.42
Joint pain 0.97 1.30 2.84 1.43 <0.001 −1.37
Dizziness 0.22 0.60 0.52 0.90 0.478
−
Shaking 0.17 0.55 0.42 0.90 <0.001 −0.34
Hot–cold spells 0.66 1.20 1.11 1.44 <0.001 −0.34
Personality
Extraversion 3.58 1.56 3.86 1.58 <0.001 −0.18
Agreeableness 2.40 1.09 2.39 1.10 <0.001 0.00
Emotional instability 3.14 1.37 3.50 1.40 <0.001 −0.26
Conscientiousness 1.95 0.92 1.99 1.00 <0.001 −0.04
Openness to new experiences 3.19 1.25 3.20 1.23 <0.001 −0.00
Coping strategies
Emotional support 5.50 1.65 5.16 1.57 <0.001 0.21
Behavioral disengagement 2.87 1.20 3.00 1.21 <0.001 −0.11
Active coping 6.09 1.39 5.95 1.42 <0.001 0.10
Self-distraction 4.91 1.50 5.13 1.43 <0.001 −0.15
Focus and venting of emotions 4.34 1.43 4.34 1.46 <0.001 0.00
Instrumental social support 5.46 1.59 5.17 1.54 <0.001 0.19
Positive reinforcement 5.53 1.45 5.53 1.49 <0.001 0.00
Restraint 4.60 1.61 4.93 1.67 <0.001 −0.20
Planning 6.13 1.39 6.10 1.42 <0.001 0.02
Humor 4.06 1.66 4.23 1.69 <0.001 −0.10
Acceptance 6.01 1.39 6.03 1.40 <0.001 −0.01
Religious coping 3.75 2.08 3.76 2.05 <0.001 −0.00
Denial 2.99 1.25 3.12 1.28 <0.001 0.10
Substance Use 2.68 1.26 2.72 1.42 <0.001 0.03
Abbreviations: CWP, chronic widespread musculoskeletal pain; M, mean; SD, standard deviation; AS, anxiety sensitivity.
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Table 2 Results of ANOVA (Kruskal–Wallis test) for the means of the 11 co-symptoms across the three CWP groups as identified 
by the LCA
CWP1 (n=123) CWP2 (n = 306) CWP3 (n = 43) c2 Contrasts
M SD M SD M SD
Fatigue 1.50 1.32 2.41 1.50 2.57 1.27 4.7 –
Migraine 0.28 0.45 0.33 0.47 0.35 0.49 0.6 –
Heartburn 1.46 0.50 1.64 0.48 1.69 0.47 12.2 1<2, 1<3
Headache 1.07 1.19 1.04 1.07 1.78 1.35 11.4 1<3, 2<3
Backache 1.24 1.31 2.51 1.45 2.44 1.45 57.1 1<2, 1<3
Insomnia 1.05 1.25 1.82 1.41 2.35 1.33 34.6 1<2, 1<3, 2<3
Stiffness 0.59 0.72 3.49 0.68 3.07 1.20 255.7 1<2, 1<3, 2<3
Palpitation 0.54 1.00 0.68 1.06 1.33 1.39 14.8 1<3, 2<3
Joint pain 1.44 1.39 3.52 0.84 3.28 1.08 152.8 1<2, 1<3
Dizziness 0.35 0.74 0.45 0.82 1.36 1.23 39.9 1<3, 2<3
Shaking 0.10 0.33 0.17 0.37 2.69 0.78 205.8 1<3, 2<3
Hot–cold spells 0.75 1.21 1.14 1.45 2.02 1.61 22.0 1<2, 1<3, 2<3
Abbreviations: ANOVA, analysis of variance; CWP, chronic widespread musculoskeletal pain; LCA, latent class analysis; M, Mean; SD, standard deviation.
Table 3 Comparison of the psychological comorbidities, personality factors, and behavioral coping strategies across the three CWP 
groups
CWP1 (n = 123) CWP2 (n = 306) CWP3 (n = 43) c2 Contrasts
M SD M SD M SD
Age 59.57 11.87 63.27 10.52 62.85 9.08 9.2 1<2
Medical condition 0.27 0.45 0.32 0.47 0.43 0.51 1.2 –
AS 13.99 8.30 15.80 10.14 21.91 10.92 12.7 1<3, 2<3
Depression 0.35 0.48 0.47 0.50 0.70 0.47 11.4 1<3, 2<3
Personality
Extraversion 4.13 1.55 3.68 1.61 4.34 1.27 8.9 1>2, 2<3
Agreeableness 2.49 1.21 2.36 1.08 2.32 0.91 0.6 –
Emotional instability 3.29 1.41 3.51 1.39 4.08 1.26 7.5 1<3, 2<3
Conscientiousness 1.90 1.03 2.03 0.96 2.00 1.18 2.6 –
Openness to new experiences 3.16 1.13 3.19 1.30 3.44 1.05 1.5 –
Coping strategies
Emotional support 5.11 1.48 5.12 1.62 5.55 1.55 2.5 –
Behavioral disengagement 3.08 1.24 2.92 1.15 3.27 1.48 2.7 –
Active coping 5.92 1.32 5.99 1.46 5.73 1.47 1.1 –
Self-distraction 4.97 1.38 5.14 1.44 5.47 1.48 3.4 –
Focus and venting of emotions 4.41 1.43 4.35 1.47 4.08 1.44 1.3 –
Instrumental social support 5.18 1.50 5.18 1.57 5.10 1.48 0.1 –
Positive reinforcement 5.33 1.39 5,54 1.49 5.97 1.70 5.8 –
Restraint 4.90 1.55 4.91 1.74 5.17 1.53 1.5 –
Planning 5.99 1.34 6.17 1.43 6.00 1.55 1.9 –
Humor 4.07 1.55 4.30 1.72 4.25 1.84 0.6 –
Acceptance 5.85 1.36 6.12 1.43 6.03 1.33 3.2 –
Religious coping 3.68 1.91 3.85 2.16 3.40 1.71 0.8 –
Denial 3.00 1.21 3.14 1.27 3.35 1.49 1.9 –
Substance use 2.70 1.25 2.69 2.43 3.00 1.72 1.5 –
Abbreviations: CWP, chronic widespread musculoskeletal pain; M, mean; SD, standard deviation; AS, anxiety sensitivity.
A study by Tsao et al38 conducted on 240 children, e.g., found 
greater AS to be significantly associated not only with cur-
rent pain but also with somatization. Other studies have also 
reported high levels of pain-related AS in individuals with 
depressive disorder, which shows an equally strong clinical 
overlap with CWP.39 A recent twin study conducted by our 
research group even suggests a shared genetic basis, and 
hence common etiology, to CWP and depression.20 Whether 
the higher rates of depression and AS in our third somatizing 
CWP group are a promoter or the consequence of somatic 
co-symptoms has to be further explored in future studies of 
different design.
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A second noteworthy finding is that CWP subgroup 3 
reporting more co-symptomatology also scored highest in 
emotional instability. Many of the previous studies inves-
tigating how affect and emotional processing influence the 
experience of pain have focused on the role of negative affect 
and CWP-related symptoms, including increased perception 
of pain intensity and chronic fatigue.22,40,41 In a large twin 
study, e.g., Kato et al found emotional instability to be a 
premorbid predictor of chronic fatigue, with shared genetic 
mechanisms underlying the expression of the disorder. It is 
therefore likely that emotional regulation and its correlates 
(such as emotional instability) are linked to CWP as well. In 
the twin study by our research group, we also found a strong 
link between emotional instability, CWP, and depression, 
highlighting further the complex multifactorial pathogenesis 
of pain.20 In accordance with these previous findings, indi-
viduals with more co-symptoms reported greater emotional 
instability and a lower ability to remain calm when under 
stress and to react with less aggressive and volatile behavior.
Interestingly, none of the groups differed in any of the 
behavioral coping strategies. In other words, the behavioral 
and psychological strategies that individuals employ to master 
and minimize stressful events, or in this specific case to cope 
with chronic pain, appeared uninfluenced by the amount and 
severity of co-symptomatology. This finding is somewhat sur-
prising as a number of studies have suggested a link between 
adaptive and maladaptive coping strategies and adjustment in 
chronic pain patients.11,14,42 According to our results, however, 
there seems to be no relationship between the specific strategy 
applied to cope with pain and potential additional somatiza-
tion. It is possible that the effects of coping were moderated 
or mediated by our other variables, such as personality that 
would mask the effects of adaptive vs. maladaptive coping 
strategies. It is also plausible that CWP individuals tend to use 
similar coping strategies, so that the lack of variation within 
these strategies might explain the fact that no differences could 
be found within this specific CWP population.
Strengths and limitations
This study has several potential limitations. First, we relied 
on questionnaires to diagnose CWP rather than clinical or 
diagnostic interviews. Thus, our discussion focuses on CWP 
only on a symptom level and not as a diagnosable disorder. 
Second, we used a cross-sectional design therefore direction 
of effect could not be determined. At this stage, it is therefore 
impossible to say whether the higher rates of depression and 
anxiety in the high co-symptomatology group are a con-
sequence of the high additional symptom load or whether 
they represent risk factors for the development of additional 
somatic symptoms. Third, the results of the LCA are depen-
dent on the items analyzed, and the list was restricted to 12 
symptoms.
Conclusion
Overall, the present findings of three distinct CWP subgroups 
depending on somatic co-symptoms demonstrate the hetero-
geneity of CWP. Accurate phenotype description is further 
crucial for successful research, and more attention should be 
paid to defining the subgroups within CWP. This will result in 
targeting therapies better and a stratified approach to patient 
care. For example, the CWP subgroup with high levels of 
co-symptoms and anxiety and depression may benefit more 
than the other subgroups from cognitive behavioral therapy.
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